Low-dose, low-risk NSAIDs best for first-line therapy

1996 ◽  
Vol &NA; (608) ◽  
pp. 3
Author(s):  
&NA;
Keyword(s):  
Low Dose ◽  
Low Risk ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility

2010 ◽  
Vol 46 (6) ◽  
pp. 892-898 ◽  
Author(s):  
Y Wang ◽  
L P Xu ◽  
K Y Liu ◽  
D H Liu ◽  
J Wang ◽  
...  
Keyword(s):  
Low Dose ◽  
Acute Gvhd ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase I/II study of low-dose cytarabine (LDAC) with sorafenib as first-line therapy of elderly patients with AML or high-risk myelodysplastic syndrome (MDS).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 6564-6564 ◽  
Author(s):  
D. A. Macdonald ◽  
S. E. Assouline ◽  
J. Brandwein ◽  
S. Kamel-Reid ◽  
E. A. Eisenhauer ◽  
...  
Keyword(s):  
High Risk ◽  
Elderly Patients ◽  
Myelodysplastic Syndrome ◽  
Phase I ◽  
Low Dose ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Low Dose Cytarabine

scholarly journals Efficacy and Safety of Weekly Low Dose Paclitaxel and Cisplatin as First Line Therapy in Advanced NSCLC of Elderly Patients

2007 ◽  
Vol 6 (2) ◽  
pp. 85
Author(s):  
Jung Ho Lee ◽  
Mi Hye Kwon ◽  
Ji Hyun Jeoung ◽  
Go Eun Lee ◽  
Eu Gene Choi ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Low Dose ◽  
Advanced Nsclc ◽  
Efficacy And Safety ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document